site stats

Morphic therapeutics market cap

WebApr 12, 2024 · Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, … WebWALTHAM, Mass., May 17, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin …

Morphic Announces Pricing of Upsized Initial ... - Morphic …

Web1 hour ago · In a report released today, Gregory Renza from RBC Capital reiterated a Buy rating on Nurix Therapeutics ( NRIX – Research Report ), with a price target of $30.00. The company’s shares opened ... WebApr 14, 2024 · Akero Therapeutics, Inc. ( NASDAQ:AKRO - Get Rating) - Lifesci Capital issued their Q1 2024 EPS estimates for Akero Therapeutics in a research report issued to clients and investors on Tuesday, April 11th. Lifesci Capital analyst P. Dolezal anticipates that the company will earn ($0.58) per share for the quarter. photo editing software browser https://jfmagic.com

Morphic Holding Inc (MORF) Stock Price & News - Google Finance

WebMar 1, 2024 · Market Cap. Today's Change (2.77%) $0.95. Current ... Shares of Morphic Holding ... which focuses on developing integrin therapeutics for conditions for which there are few adequate therapy ... WebMar 3, 2024 · WALTHAM, Mass., March 02, 2024 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced the pricing of an upsized underwritten public offering of 3,500,000 shares of its common … WebOperating Status Active. Last Funding Type Post-IPO Equity. Legal Name Morphic Holding, LLC. Stock Symbol NASDAQ:MORF. Company Type For Profit. Contact Email … photo editing software chromebook

Press Releases – Morphic Therapeutic

Category:Morphic Therapeutic (MORF) - EPS (earnings per share)

Tags:Morphic therapeutics market cap

Morphic therapeutics market cap

Morphic Holding (Nasdaq:MORF) - Stock Price, News & Analysis

WebMorphic Market Cap: 1.488B for March 31, 2024. Market Cap Chart. Historical Market Cap Data. View and export this data back to 2024. Upgrade now. Date Value; March 30, 2024: 1.473B March 29, 2024: 1.498B March 28 ... WebRevenue for Morphic Therapeutic (MORF) Revenue in 2024 (TTM): $70.8 M According to Morphic Therapeutic's latest financial reports the company's current revenue (TTM) is …

Morphic therapeutics market cap

Did you know?

WebCurrent and historical EPS charts for Morphic Therapeutic. As of March 2024 Morphic Therapeutic's TTM earnings per share are -$1.62. companies: 7,317 total market cap: … WebApr 9, 2024 · The last twelve months weren't great for Morphic Holding shares, which performed worse than the market, costing holders 16%. The market shed around 9.2%, no doubt weighing on the stock price. Fortunately the longer term story is brighter, with total returns averaging about 31% per year over three years.

WebMar 2, 2024 · Jefferies, Cowen, BMO Capital Markets and RBC Capital Markets are acting as joint bookrunners for the offering. Morphic intends to use the net proceeds from the … WebJan 5, 2024 · Morphic to Present at the 41st Annual J.P. Morgan Healthcare Conference January 5, 2024 WALTHAM, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced …

WebGet the latest Morphic Holding Inc (MORF) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. WebJun 26, 2024 · WALTHAM, Mass.--(BUSINESS WIRE)--Jun. 26, 2024-- Morphic Holding, Inc. (“ Morphic ”), a biopharmaceutical company discovering and developing oral small-molecule integrin therapeutics, today announced the pricing of its upsized initial public offering of 6,000,000 shares of its common stock at a price to the public of $15.00 per …

WebMorphic Market Cap: 1.488B for March 31, 2024. Market Cap Chart. Historical Market Cap Data. View and export this data back to 2024. Upgrade now. Date Value; March 30, …

photo editing software closesWebMar 1, 2024 · WALTHAM, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a new generation... how does eastern culture view healthWebMar 24, 2024 · Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, ... Morphic Holding 's market cap is calculated by multiplying MORF's current stock price of $37.63 by MORF's total outstanding shares of … photo editing software cnetWebAs of April 2024 Morphic Therapeutic has a market cap of $1.48 Billion. This makes Morphic Therapeutic the world's 4142th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total … how does earth\u0027s rotation cause day and nightWebMorphic Therapeutic (NASDAQ: MORF) develops oral integrin therapies for immunological, fibrotic, neoplastic and vascular diseases. Use the CB Insights Platform to explore Morphic Therapeutic's full profile. ... Market Cap 1.65B. Stock Price 41.82. About Morphic Therapeutic. how does earwax form in your earWebMorphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins … how does easter fall each yearWebApr 14, 2024 · BioXcel Therapeutics Inc. (BTAI) current stock price is $19.14. During the last trading session, the stock soared, reaching $19.71 after opening at $16.89. The stock’s lowest point was $16.88 before it closed at $16.69. The market performance of BioXcel Therapeutics Inc. has been somewhat stable. how does eastern orthodox worship